Liver cirrhosis Usama Ahmed Arafa MD Ass Professor

  • Slides: 42
Download presentation
Liver cirrhosis Usama Ahmed Arafa, MD Ass. Professor of Internal Medicine

Liver cirrhosis Usama Ahmed Arafa, MD Ass. Professor of Internal Medicine

Definition

Definition

Liver cirrhosis is characterized by: 1 - Hepatocellular necrosis 2 - Hepatic fibrosis 3

Liver cirrhosis is characterized by: 1 - Hepatocellular necrosis 2 - Hepatic fibrosis 3 - Regeneration nodules 4 - Loss of architecture

Normal Liver

Normal Liver

Cirrhosis

Cirrhosis

Normal Liver Histology CV PT

Normal Liver Histology CV PT

Cirrhosis Fibrosis Regenerating Nodule

Cirrhosis Fibrosis Regenerating Nodule

Etiology

Etiology

Common causes • Chronic viral hepatitis: C, B ± D • Alcohol • Schistosomiasis

Common causes • Chronic viral hepatitis: C, B ± D • Alcohol • Schistosomiasis (fibrosis not true LC) Less Common causes • Biliary cirrhosis: - primary - secondary • Autoimmune hepatitis • Hereditary: - Haemochromatosis - Wilson's disease - Alpha 1 antitrypsin deficiency

 • Drugs (e. g. methotrexate) • Cystic fibrosis • Non-alcoholic fatty liver disease

• Drugs (e. g. methotrexate) • Cystic fibrosis • Non-alcoholic fatty liver disease (NAFLD) • Glycogen storage disease • Veno-occlusive disease • Hepatic venous congestion • Budd-Chiari syndrome • Idiopathic (cryptogenic)

Pathogenesis

Pathogenesis

 • Chronic injury to the liver results in inflammation, necrosis and, eventually, fibrosis.

• Chronic injury to the liver results in inflammation, necrosis and, eventually, fibrosis. • Fibrosis is initiated by activation of the stellate cells.

 • In the space of Disse, the normal matrix is replaced by collagen.

• In the space of Disse, the normal matrix is replaced by collagen. Subendothelial fibrosis leads to loss of the endothelial fenestrations, and this impairs liver function. • There is accumulating evidence that liver fibrosis is reversible.

 • Pathogenesis of fibrosis

• Pathogenesis of fibrosis

Pathological Types

Pathological Types

Micronodular cirrhosis: Regenerating nodules are usually less than 3 mm in size. This type

Micronodular cirrhosis: Regenerating nodules are usually less than 3 mm in size. This type is often caused by alcoholic or biliary cirrhosis. Macronodular cirrhosis: The nodules are of variable size and normal acini may be seen within the larger nodules. This type is often seen following previous hepatitis. A mixed picture: with small and large nodules is sometimes seen.

Micronodular cirrhosis

Micronodular cirrhosis

Micronodular cirrhosis:

Micronodular cirrhosis:

Macronodular Cirrhosis

Macronodular Cirrhosis

Symptoms and Signs

Symptoms and Signs

A- General manifestations • Wasting • Parotid enlargement • Hyperkinetic circulation • Increased susceptibility

A- General manifestations • Wasting • Parotid enlargement • Hyperkinetic circulation • Increased susceptibility to infection

B- Skin manifestations • Spider nevi • Palmar erythema • Leuconychia • Dupuytren’s contractures

B- Skin manifestations • Spider nevi • Palmar erythema • Leuconychia • Dupuytren’s contractures • Xanthomas • Alternation of body hair distribution

C- Endocrinal manifestations • Gynecomastia • Testicular atrophy • Amenorrhea in females

C- Endocrinal manifestations • Gynecomastia • Testicular atrophy • Amenorrhea in females

Gynecomastia in cirrhosis

Gynecomastia in cirrhosis

D- Abdominal manifestations • Hepatomegaly then shrinkage later • Splenomegaly • Prominent abdominal veins

D- Abdominal manifestations • Hepatomegaly then shrinkage later • Splenomegaly • Prominent abdominal veins • Peptic ulcer disease • Chronic pancreatitis • Steatorrhea

Portosystemic anastomosis: Prominent abdominal veins.

Portosystemic anastomosis: Prominent abdominal veins.

E- Decompensation • Jaundice • Ascitis • Bleeding tendency • Hepatic encephalopathy

E- Decompensation • Jaundice • Ascitis • Bleeding tendency • Hepatic encephalopathy

Physical signs in liver cirrhosis.

Physical signs in liver cirrhosis.

Investigations

Investigations

Investigations for severity § Liver function. Serum albumin and prothrombin time are the best

Investigations for severity § Liver function. Serum albumin and prothrombin time are the best indicators of liver function. ■ Liver biochemistry. In most cases there is a slight elevation in the serum ALP and serum aminotransferases. ■ Serum electrolytes. A low sodium indicates severe liver disease.

Investigations for the etiology • • • Viral markers Serum autoantibodies Iron indices and

Investigations for the etiology • • • Viral markers Serum autoantibodies Iron indices and ferritin Copper, ceruloplasmin Alpha 1 antitrypsin (Serum copper and alpha 1 antitrypsin should always be measured in young cirrhotics)

Others • Ultrasound examination. • CT scan. • MRI scan. • Endoscopy. • Liver

Others • Ultrasound examination. • CT scan. • MRI scan. • Endoscopy. • Liver biopsy.

Management

Management

► Management is that of complications. ► Patients should have 6 -monthly ultrasound and

► Management is that of complications. ► Patients should have 6 -monthly ultrasound and serum AFP to detect the development of a hepatocellular carcinoma as early as possible. ► There is no treatment that will arrest or reverse the cirrhotic changes although progression may be halted by correcting the underlying cause.

► Patients with compensated cirrhosis should lead a normal life. ► The only dietary

► Patients with compensated cirrhosis should lead a normal life. ► The only dietary restriction is to reduce salt intake. ► Aspirin and NSAIDs should be avoided. ► Alcohol should be avoided.

LIVER TRANSPLANTATION ► This is an established treatment for a number of liver diseases.

LIVER TRANSPLANTATION ► This is an established treatment for a number of liver diseases. ► Shortage of donors is a major problem in all developed countries.

Course and Prognosis

Course and Prognosis

Child's-Pugh classification Score • • • 1 Ascites None Encephalopathy None Bilirubin < 2

Child's-Pugh classification Score • • • 1 Ascites None Encephalopathy None Bilirubin < 2 mg/d. L Albumin > 3. 5 (g/d. L) Prothrombin time < 4 seconds (Scores) Child's A (< 7) Child's B (7 -9) Child's C (10+) 1 -year survival 82 62 42 2 3 Mild 2 -3 3. 5 -2. 8 4 -6 Moderate/severe Marked >3 < 2. 8 >6 5 years 45 20 20 10 years 25 7 0

COMPLICATIONS AND EFFECTS OF CIRRHOSIS

COMPLICATIONS AND EFFECTS OF CIRRHOSIS

► Portal hypertension and gastrointestinal haemorrhage ► Ascites ► Portosystemic encephalopathy ► Renal failure

► Portal hypertension and gastrointestinal haemorrhage ► Ascites ► Portosystemic encephalopathy ► Renal failure (hepatorenal syndrome) ► Hepatopulmonary syndrome ► Hepatocellular carcinoma ► Bacteraemias, infections ► Malnutrition

Ascites in Cirrhosis

Ascites in Cirrhosis

Hepatocellular Carcinoma

Hepatocellular Carcinoma